Transcranial Magnetic Stimulation in Misophonia

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 2, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Misophonia
Interventions
OTHER

Transcranial Magnetic Stimulation (TMS)

Transcranial Magnetic Stimulation (TMS) is an FDA-approved non-invasive brain stimulation technology. It is currently used for treating depression. Applications to other disorders such as OCD and anxiety using TMS are currently under investigation. TMS will be administered for 25 minutes.

Trial Locations (1)

10022

RECRUITING

Mount Sinai West, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT06960083 - Transcranial Magnetic Stimulation in Misophonia | Biotech Hunter | Biotech Hunter